Motixafortide
Motixafortide is a novel therapeutic agent that is being investigated for its potential use in various medical conditions, particularly in oncology and hematology. It is a synthetic peptide that functions as a high-affinity antagonist of the CXCR4 receptor, which plays a crucial role in the tumor microenvironment and hematopoiesis.
Mechanism of Action
Motixafortide binds to the CXCR4 receptor, inhibiting its interaction with its natural ligand, stromal cell-derived factor-1 (SDF-1), also known as CXCL12. This inhibition disrupts the CXCR4/CXCL12 axis, which is involved in the homing and retention of hematopoietic stem cells (HSCs) in the bone marrow. By blocking this pathway, motixafortide mobilizes HSCs into the peripheral blood, making them more accessible for collection and subsequent hematopoietic stem cell transplantation.
Clinical Applications
Oncology
In the field of oncology, motixafortide is being studied for its potential to enhance the efficacy of chemotherapy and immunotherapy. The CXCR4/CXCL12 axis is known to contribute to tumor growth, metastasis, and tumor resistance to therapy. By inhibiting this pathway, motixafortide may help to sensitize tumors to treatment and inhibit their progression.
Hematology
Motixafortide is also being investigated for its role in hematopoietic stem cell transplantation. By mobilizing HSCs from the bone marrow into the peripheral blood, it facilitates their collection for transplantation procedures. This can be particularly beneficial for patients requiring autologous or allogeneic stem cell transplants.
Development and Research
Motixafortide is currently undergoing clinical trials to evaluate its safety and efficacy in various indications. Preliminary results have shown promise, particularly in the mobilization of HSCs and in combination with other therapeutic agents in cancer treatment.
See Also
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD